Expert Opinion on Therapeutic Targets

1

Targeting CD73 and downstream adenosine receptor signaling in triple-negative breast cancer

Allard, Bertrand, Turcotte, Martin, Stagg, John

Journal:

Year:

2014

Language:

english

File:

PDF, 718 KB

english, 2014

2

PAR-4: a possible new target for age-related disease

Qinan, Wu, Ling, Zhang, Bing, Chen

Journal:

Expert Opinion on Therapeutic Targets

Year:

2014

Language:

english

File:

PDF, 972 KB

english, 2014

3

Counteracting antibiotic resistance: breaking barriers among antibacterial strategies

Baquero, Fernando, Coque, Teresa M, Cantón, Rafael

Journal:

Expert Opinion on Therapeutic Targets

Year:

2014

Language:

english

File:

PDF, 377 KB

english, 2014

4

Therapeutic potential of STAT4 in autoimmunity

Liang, Yan, Pan, Hai-Feng, Ye, Dong-Qing

Journal:

Expert Opinion on Therapeutic Targets

Year:

2014

Language:

english

File:

PDF, 650 KB

english, 2014

5

Activating human genes with zinc finger proteins, transcription activator-like effectors and CRISPR/Cas9 for gene therapy and regenerative medicine

Gersbach, Charles A, Perez-Pinera, Pablo

Journal:

Expert Opinion on Therapeutic Targets

Year:

2014

Language:

english

File:

PDF, 264 KB

english, 2014

6

Heat shock protein 70 – the next chaperone to target in the treatment of human acute myelogenous leukemia?

Reikvam, Håkon, Brenner, Annette K, Nepstad, Ina, Sulen, André, Bruserud, Øystein

Journal:

Expert Opinion on Therapeutic Targets

Year:

2014

Language:

english

File:

PDF, 635 KB

english, 2014

7

Osteopontin as a therapeutic target for cancer

Bandopadhyay, Monalisa, Bulbule, Anuradha, Butti, Ramesh, Chakraborty, Goutam, Ghorpade, Priyanka, Ghosh, Pompom, Gorain, Mahadeo, Kale, Smita, Kumar, Dhiraj, Kumar, Santosh, Totakura, Kumar VS, Roy,

Journal:

Expert Opinion on Therapeutic Targets

Year:

2014

Language:

english

File:

PDF, 874 KB

english, 2014

8

Germline copy number variation in the YTHDC2 gene: does it have a role in finding a novel potential molecular target involved in pancreatic adenocarcinoma susceptibility?

Fanale, Daniele, Iovanna, Juan Lucio, Calvo, Ezequiel Luis, Berthezene, Patrice, Belleau, Pascal, Dagorn, Jean Charles, Bronte, Giuseppe, Cicero, Giuseppe, Bazan, Viviana, Rolfo, Christian, Santini, D

Journal:

Expert Opinion on Therapeutic Targets

Year:

2014

Language:

english

File:

PDF, 598 KB

english, 2014

9

Oncogenic role and therapeutic target of leptin signaling in colorectal cancer

Zhou, Weiqiang, Tian, Yuwang, Gong, Hangjun, Guo, Shanchun, Luo, Chengyu

Journal:

Expert Opinion on Therapeutic Targets

Year:

2014

Language:

english

File:

PDF, 478 KB

english, 2014

10

AKT as a therapeutic target in multiple myeloma

Keane, Niamh A, Glavey, Siobhan V, Krawczyk, Janusz, O’Dwyer, Michael

Journal:

Expert Opinion on Therapeutic Targets

Year:

2014

Language:

english

File:

PDF, 688 KB

english, 2014

11

Volume 18; Issue 8

Expert Opinion on Therapeutic Targets

Targeting CD73 and downstream adenosine receptor signaling in triple-negative breast cancer

PAR-4: a possible new target for age-related disease

Counteracting antibiotic resistance: breaking barriers among antibacterial strategies

Therapeutic potential of STAT4 in autoimmunity

Activating human genes with zinc finger proteins, transcription activator-like effectors and CRISPR/Cas9 for gene therapy and regenerative medicine

Heat shock protein 70 – the next chaperone to target in the treatment of human acute myelogenous leukemia?

Osteopontin as a therapeutic target for cancer

Germline copy number variation in the YTHDC2 gene: does it have a role in finding a novel potential molecular target involved in pancreatic adenocarcinoma susceptibility?

Oncogenic role and therapeutic target of leptin signaling in colorectal cancer

AKT as a therapeutic target in multiple myeloma

Related articles